Literature DB >> 11005267

Urinary cortisol to cortisone metabolites in hypertensive obese children.

G Y Csábi1, S Juricskay, D Molnár.   

Abstract

Childhood obesity is accompanied by a variety of cardiovascular risk factors (hypertension, insulin resistance, dyslipidaemia) which tend to aggregate (syndrome X). 11beta-hydroxysteroid dehydrogenase (11beta-HSD) is supposed to play a role in the pathogenesis of hypertension and the development of syndrome X. There are two isoforms of 11beta-HSD. 11beta-HSD-2 is responsible for the inactivation of cortisol to inactive cortisone. In the case of impaired enzyme activity the ratio of urinary tetrahydrocortisol (THF)+ its isomer allotetrahydrocortisol (5alpha-THF)/tetrahydrocortisone (THE) is elevated. 11beta-HSD-1 is an oxo-reductase, which type catalyses the conversion of cortisone to cortisol. The aim of the present study was to investigate if there was any alteration in the urinary cortisol metabolites reflecting 11beta-HSD activity in hypertensive obese children (no.=15) as compared to normotensive obese (no.=11) and normotensive non-obese children (no.=15). We found an increased excretion of cortisol metabolites in hypertensive obese children compared to obese and normal - weight children having normal blood pressure. The ratio of THF+5alpha(THF/THE had a significant correlation with systolic blood pressure. On the basis of our study the ratio of THF+5alpha-THF/ THE reflecting on altered enzyme activity seems to be an independent factor influencing especially systolic blood pressure in hypertensive obese children.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11005267     DOI: 10.1007/bf03343752

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  26 in total

1.  Does central obesity reflect "Cushing's disease of the omentum"?

Authors:  I J Bujalska; S Kumar; P M Stewart
Journal:  Lancet       Date:  1997-04-26       Impact factor: 79.321

2.  Carbenoxolone increases hepatic insulin sensitivity in man: a novel role for 11-oxosteroid reductase in enhancing glucocorticoid receptor activation.

Authors:  B R Walker; A A Connacher; R M Lindsay; D J Webb; C R Edwards
Journal:  J Clin Endocrinol Metab       Date:  1995-11       Impact factor: 5.958

3.  Mass spectrometry in the diagnosis of steroid-related disorders and in hypertension research.

Authors:  C H Shackleton
Journal:  J Steroid Biochem Mol Biol       Date:  1993-04       Impact factor: 4.292

4.  Report of the Second Task Force on Blood Pressure Control in Children--1987. Task Force on Blood Pressure Control in Children. National Heart, Lung, and Blood Institute, Bethesda, Maryland.

Authors: 
Journal:  Pediatrics       Date:  1987-01       Impact factor: 7.124

5.  The human gene for 11 beta-hydroxysteroid dehydrogenase. Structure, tissue distribution, and chromosomal localization.

Authors:  G M Tannin; A K Agarwal; C Monder; M I New; P C White
Journal:  J Biol Chem       Date:  1991-09-05       Impact factor: 5.157

6.  Glucocorticoids and blood pressure: a role for the cortisol/cortisone shuttle in the control of vascular tone in man.

Authors:  B R Walker; A A Connacher; D J Webb; C R Edwards
Journal:  Clin Sci (Lond)       Date:  1992-08       Impact factor: 6.124

7.  Simultaneous estimation of urinary steroids by semi-automated gas chromatography. Investigation of neo-natal infants and children with abnormal steroid synthesis.

Authors:  C H Shackleton; J W Honour
Journal:  Clin Chim Acta       Date:  1976-06-01       Impact factor: 3.786

8.  Evidence of coexisting changes in 11 beta-hydroxysteroid dehydrogenase and 5 beta-reductase activity in subjects with untreated essential hypertension.

Authors:  A Soro; M C Ingram; G Tonolo; N Glorioso; R Fraser
Journal:  Hypertension       Date:  1995-01       Impact factor: 10.190

Review 9.  Functional studies of 11 beta-hydroxysteroid dehydrogenase.

Authors:  P C White; T Mune; A K Agarwal
Journal:  Steroids       Date:  1995-01       Impact factor: 2.668

10.  Human hypertension caused by mutations in the kidney isozyme of 11 beta-hydroxysteroid dehydrogenase.

Authors:  T Mune; F M Rogerson; H Nikkilä; A K Agarwal; P C White
Journal:  Nat Genet       Date:  1995-08       Impact factor: 38.330

View more
  4 in total

1.  G6PT-H6PDH-11βHSD1 triad in the liver and its implication in the pathomechanism of the metabolic syndrome.

Authors:  Ibolya Czegle; Miklós Csala; József Mandl; Angelo Benedetti; István Karádi; Gábor Bánhegyi
Journal:  World J Hepatol       Date:  2012-04-27

Review 2.  The Role of Aldosterone in Obesity-Related Hypertension.

Authors:  Wakako Kawarazaki; Toshiro Fujita
Journal:  Am J Hypertens       Date:  2016-02-28       Impact factor: 2.689

3.  Role of glucocorticoid metabolism in childhood obesity-associated hypertension.

Authors:  Martijn J J Finken; Aleid J G Wirix; Ines A von Rosenstiel-Jadoul; Bibian van der Voorn; Mai J M Chinapaw; Michaela F Hartmann; Joana E Kist-van Holthe; Stefan A Wudy; Joost Rotteveel
Journal:  Endocr Connect       Date:  2022-07-14       Impact factor: 3.221

4.  Is There an Association Between Cortisol and Hypertension in Overweight or Obese Children?

Authors:  Aleid Jg Wirix; Martijn Jj Finken; Ines A von Rosenstiel-Jadoul; Annemieke C Heijboer; Jeroen Nauta; Jaap W Groothoff; Mai Jm Chinapaw; Joana E Kist-van Holthe
Journal:  J Clin Res Pediatr Endocrinol       Date:  2017-07-17
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.